News | MRI Breast | February 10, 2017

Rapid Breast MRI Screening Improves Cancer Detection in Dense Breasts

New method cuts screening time to 7 minutes while increasing early detection rates

A new method for screening women with dense breast tissue may potentially save thousands of lives

February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives by detecting breast cancer four to six years earlier than mammographic technology.

Due to its cost, breast imaging using magnetic resonance imaging (MRI) is recommended only for women at high risk for cancer — an estimated 2 percent of women. Mammograms are the current standard for the rest of the population.

The new Rapid Breast MRI protocol — derived from original research by David A. Strahle, M.D., chairman of Regional Medical Imaging in Flint, Mich. — cuts scan time by 70 percent to only 7 minutes, significantly reducing costs and enabling its use for screening women with dense breasts. In conjunction with a local HMO, Strahle found that early detection would have major costs savings for both women and insurance companies when considering the 10 categories of expense dealing with breast cancer.

Read the article "From Aviation to Breast Imaging - Development of an Abbreviated Breast MRI Protocol"

Mammographic technology for women with dense breast tissue is simply not as effective as MRI in spotting cancer, Strahle noted. In addition, unlike tomosynthesis (3-D mammography) or mammograms, MRIs do not use X-ray radiation.

“It’s like trying to see a thunderstorm through clouds without radar,” Strahle said. “MRI sees through the dense tissue, allowing radiologists to spot virtually all suspicious tumors.”

The new MRI protocol allows screening of women on a regular basis who have dense breast tissue. Strahle conducted peer-reviewed research of 671 women over seven years, which was published on Jan. 30, 2017. The research also includes an easier method for radiologists to read the exams, greatly lowering the false positive rate to below that of any other breast screening method.

Although insurance providers do not yet cover Rapid Breast MRI, the exam costs $395 out-of-pocket at RMI, compared with a diagnostic MRI that runs $700 or more. In addition to reducing scan time, screening Rapid Breast MRI can potentially be conducted every other year, instead of yearly as with mammograms. This equates to an annual cost of only $198, less than the average breast screening costs of $252 in mid-Michigan, Strahle said.

Read the article "Breast MRI in Cancer Diagnosis"

Breast cancer continues to be a leading cause of death in women. About one in eight women will develop breast cancer in their lifetimes, with 85 percent of those cancers occurring in women with no family history, according to breastcancer.org.

The research was published Jan. 30 in the journal Breast Cancer Research and Treatment.

For more information: www.link.springer.com

Related Breast MRI Content

VIDEO: Developments in Breast Density Legislation and Screening Guidelines

VIDEO: What is New in Breast Imaging Technology

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients

References

Strahle, D.A., Pathak, D.R., Sierra, A., Saha, S., et al. "Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging," Breast Cancer Research and Treatment. Published online Jan. 30, 2017. DOI: 10.1007/s10549-017-4112-0

Related Content

Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
News | Mammography | November 20, 2020
November 20, 2020 — Densitas Inc., a global provider of A.I.
Radiologists around the world will have access to a first-of-its-kind online breast density training tool designed to improve radiologists' ability to correctly identify women's breast density categories to comply with the Breast Imaging-Reporting and Data System (BI-RADS), thanks to a collaboration between DetectED-X and Volpara Health. 
News | Breast Density | November 19, 2020
November 19, 2020 — Radiologists around the world will have access to a first-of-its-kind online...
Reduces the complexity of reporting for screening and diagnostic MRI eams to deliver time-saving and patient safety benefits
News | MRI Breast | November 18, 2020
November 18, 2020 — ...
An interview with Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, on the effects on breast imaging in the COVID-19 era

Getty Images

Feature | Breast Imaging | November 12, 2020 | By Dave Fornell
The pandemic forced many elective procedures, including most areas of...
Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single

Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single-slice DBT image in craniocaudal view. C, Magnification of the lesion depicted in B. D, Image from SM in mediolateral oblique view. E, Single-slice DBT image in mediolateral oblique view. F, Magnification of the lesion depicted in E. Images courtesy of Radiological Society of North America

News | Breast Imaging | November 11, 2020
November 11, 2020 — ...
Hologic, Inc. announced innovative updates to its Unifi Analytics platform, a breakthrough business intelligence tool that provides mammography centers insights into technologist performance, proactive device maintenance, and business considerations.
News | Mammography | November 10, 2020
November 10, 2020 — Hologic, Inc.
Mammograms in a 51-year-old woman with invasive ductal carcinoma. The upper panels show the craniocaudal and the mediolateral oblique views. The lower panels show a close-up of the left breast area containing the lesion. The case is one of the false-negative cases included in the dataset. Accordingly, the initial screening assessment was a BI-RADS 2, meaning visible findings were judged as benign. After 1 year, the patient presented for another screening examination. This time, a focal asymmetry with associ

Mammograms in a 51-year-old woman with invasive ductal carcinoma. The upper panels show the craniocaudal and the mediolateral oblique views. The lower panels show a close-up of the left breast area containing the lesion. The case is one of the false-negative cases included in the dataset. Accordingly, the initial screening assessment was a BI-RADS 2, meaning visible findings were judged as benign. After 1 year, the patient presented for another screening examination. This time, a focal asymmetry with associated distortion within the left breast was noticed; the patient was recalled and diagnosed with a 1.5-cm mass in the upper outer quadrant of the left breast on the craniocaudal view (circle).

News | Mammography | November 04, 2020
November 4, 2020 — Artificial intelligen...
Innovation can help address screening backlog due to COVID-19 pandemic by streamlining breast imaging reading process
News | Breast Imaging | November 02, 2020
November 2, 2020 — Hologic, Inc. announced the commercial availability in Europe of its...